<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01079429</url>
  </required_header>
  <id_info>
    <org_study_id>RCB 2008-A01023-52</org_study_id>
    <secondary_id>AFSSAPS B80894-60</secondary_id>
    <secondary_id>IFM 08-02</secondary_id>
    <nct_id>NCT01079429</nct_id>
  </id_info>
  <brief_title>Study of DNA Copy Numbers Variations and Gene Expression Profile of Bone Marrow Plasma Cells From MGUS and SMM.</brief_title>
  <acronym>GENOMGUS</acronym>
  <official_title>Large Scale Study of DNA Copy Numbers Variations and Gene Expression Profile of Bone Marrow Plasma Cells From Monoclonal Gammopathy of Undetermined Significance (MGUS) and Indolent Myeloma (SMM).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Intergroupe Francophone du Myelome</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to describe DNA copy number variations and gene expression
      profiles of bone marrow plasma cells of monoclonal gammopathy of undetermined significance
      (MGUS) and smoldering multiple myeloma (SMM). The final objective is to search for
      correlations with the risk of progression in order to establish a predictive model of early
      malignant transformation.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Progression to symptomatic multiple myeloma</measure>
    <time_frame>Every 6 or 12 months during 5 years</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Monoclonal Gammopathy of Undetermined Significance</condition>
  <condition>Smoldering Myeloma</condition>
  <arm_group>
    <arm_group_label>MGUS or SMM</arm_group_label>
    <description>Patients with Monoclonal gammopathy of undetermined significance or smoldering myeloma</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Genetic study of DNA copies</intervention_name>
    <description>Gene expression profiling, DNA copy number variation</description>
    <arm_group_label>MGUS or SMM</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood Plasma Urine Bone marrow
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Monoclonal gammopathy of undetermined significance or Smoldering myeloma
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged from 18 to 70 years

          -  Written informed consent

          -  One of the following three criteria:

               -  Recently diagnosed IgG or IgA monoclonal gammopathy without clinical or
                  biological features of malignant hemopathy

               -  IgG or IgA MGUS regardless the date of the diagnosis

               -  SMM regardless the date of the diagnosis

          -  Normal blood count, creatininemia and calcemia *

          -  Bence-Jones proteinuria below 1g/24 hours

          -  Absence of bone pain

          -  No clinical or biological features of amyloidosis

          -  No recurrent episode of infection (more than 2 infections requiring antibiotics in the
             previous 6 months) * In case of abnormal blood count, renal failure or hypercalcemia,
             patients may be included if an intercurrent cause is identified (for example anemia
             associated with iron deficiency)

        Diagnostic criteria for MGUS:

          -  Monoclonal component concentration below 30 g / l AND

          -  Bone marrow plasmacytosis below 10%

          -  Bence-Jones proteinuria below 1g/24 hours

          -  Normal blood count, creatininemia and calcemia *

          -  Absence of bone lesions on conventional bone radiographies

          -  No clinical or biological features of amyloidosis

          -  Absence of hyperviscosity syndrome

          -  No recurrent episode of infection (more than 2 infections requiring antibiotics in the
             previous 6 months) * In case of abnormal blood count, renal failure or hypercalcemia,
             patients may be included if an intercurrent cause is identified (for example anemia
             associated with iron deficiency)

        Diagnostic criteria for SMM:

          -  Monoclonal component concentration greater than 30 g / l AND / OR

          -  Bone marrow plasmacytosis greater than 10%

          -  Bence-Jones proteinuria below 1g/24 hours

          -  Normal blood count, creatininemia and calcemia *

          -  Absence of bone lesions on conventional bone radiographies

          -  No clinical or biological features of amyloidosis

          -  Absence of hyperviscosity syndrome

          -  No recurrent episode of infection (more than 2 infections requiring antibiotics in the
             previous 6 months) * In case of abnormal blood count, renal failure or hypercalcemia,
             patients may be included if an intercurrent cause is identified (for example anemia
             associated with iron deficiency)

        Exclusion Criteria:

          -  Patients younger than 18 years

          -  Patients older than 71 years

          -  IgM monoclonal gammopathy (regardless of diagnosis)

          -  Monoclonal gammopathy associated with hematologic malignancies (multiple myeloma,
             chronic lymphocytic leukemia, ...)

          -  Patients with chronic liver disease, autoimmune or neoplastic disease for less than 5
             years

          -  Active viral hepatitis B or C

          -  HIV seropositive patient

          -  Pregnant woman

          -  Breastfeeding woman
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olivier DECAUX, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rennes University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rennes University Hospital</name>
      <address>
        <city>Rennes</city>
        <state>Bretagne</state>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <state>Pays de Loire</state>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Amiens - médecine interne</name>
      <address>
        <city>Amiens</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Angers</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier H.Duffaut - Avignon</name>
      <address>
        <city>Avignon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Jean Minjoz - Besancon</name>
      <address>
        <city>Besancon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Médecine interne - Centre Hospitalier</name>
      <address>
        <city>Blois</city>
        <zip>41016</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bordeaux Bergonié</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bordeaux Haut Leveque</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Polyclinique Bordeaux Nord Aquitaine</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital A.Morvan Brest</name>
      <address>
        <city>Brest</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre F.Baclesse</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Caen</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital d'instruction des armées Percy</name>
      <address>
        <city>Clamart</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Clermont Ferrand</name>
      <address>
        <city>Clermont Ferrand</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Colmar</name>
      <address>
        <city>Colmar</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Dijon</name>
      <address>
        <city>Dijon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHG Dunkerque</name>
      <address>
        <city>Dunkerque</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Grenoble</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH La Roche sur yon</name>
      <address>
        <city>La Roche sur yon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Laval</name>
      <address>
        <city>Laval</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Le Mans Victor Hugo</name>
      <address>
        <city>Le Mans</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Claude Huriez</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Yves Le Foll de Saint Brieuc - Service d'Hématologie</name>
      <address>
        <city>Saint Brieuc</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Toulouse Purpan</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Toulouse Rangueil</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service d'Hématologie - Hôpital de Brabois</name>
      <address>
        <city>Vandoeuvre</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2010</study_first_submitted>
  <study_first_submitted_qc>March 2, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2010</study_first_posted>
  <last_update_submitted>August 28, 2017</last_update_submitted>
  <last_update_submitted_qc>August 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Monoclonal gammopathy of undetermined significance</keyword>
  <keyword>MGUS</keyword>
  <keyword>Smoldering myeloma</keyword>
  <keyword>SMM</keyword>
  <keyword>Multiple myeloma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Myeloma</mesh_term>
    <mesh_term>Neoplasms, Plasma Cell</mesh_term>
    <mesh_term>Paraproteinemias</mesh_term>
    <mesh_term>Monoclonal Gammopathy of Undetermined Significance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

